Log In
Print this Print this

JRC-LAMP-vax vaccine

  Manage Alerts
Collapse Summary General Information
Company Immunomic Therapeutics Inc.
DescriptionPlasmid-based DNA vaccine containing the Cry J2 plasmid that uses a lysosomal-associated membrane protein (LAMP) antigen targeting sequence to enhance immune response
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationAllergic conjunctivitis
Indication DetailsTreat rhinoconjunctivitis symptoms caused by allergic reaction to Japanese red cedar pollen
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today